Home / Fibrinogen, Human / Belgium
BE ATC B02BB01 · updated 2 Nov 2026
Fibrinogen, Human shortage in Belgium
Is there a Fibrinogen, Human shortage in Belgium?
Yes. As of 2 Nov 2026, 3 Fibrinogen, Human products are reported short in Belgium, the first since 9 Oct 2025. The company estimate for the return is 31 Jan 2027 (latest 14 Jun 2027). Main reason: other.
Also short in Germany, Italy, Spain, Czechia, Norway, Sweden. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Fibclot 1.5 g inj./inf. sol. (pwdr. + solv.) i.v. vial 1.5 g + 100 ml | Laboratoire français du Fractionnement et des Biotechnologies | 9 Oct 2025 | 14 Jun 2027 | Manufacturing problem Delay in production |
| BE | Fibryga 1 g inj./inf. sol. (pwdr. + solv.) i.v. vial 1 g + 50 ml limited | Octapharma Benelux | 6 May 2026 | 31 Jan 2027 | Other Other reason |
| BE | Riastap 1 g inj./inf. sol. (pwdr.) i.v. vial 1 g limited | CSL Behring | 6 May 2026 | 31 Jan 2027 | Other Other reason |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.